[Therapy of ventricular tachyarrhythmia with implantable cardioverters/defibrillators--mortality and complications using epicardial electrodes].
Technical improvements of third generation implantable cardioverter defibrillators (ICD) like antitachycardia pacing modalities lead to an extended use of ICDs, not only in patients with aborted sudden cardiac death, but also in patients with hemodynamically tolerable ventricular tachycardia. In addition, anticipated results of current prospective studies might indicate the prophylactic use of ICDs in patients with high risk for sudden cardiac death, but without documented ventricular tachyarrhythmias. This report reviews mortality and complications associated with the ICDs with epicardial defibrillation leads. Mortality is separated in cardiac death, sudden cardiac, arrhythmogenic "not so sudden" cardiac death, and overall mortality. Pulmonary complications and infections are related to the underlying disease and the surgical procedure. Device- and lead-related complications, high defibrillation thresholds, pacemaker interactions, inappropriate shocks, arrhythmic effects, syncope, and psychosocial problems are reported, respectively.
Wietholt
D
D
Medizinische Klinik und Poliklinik, Innere Medizin C, Kardiologie und Angiologie, Westfälische Wilhelms-Universität Münster.
Block
M
M
Isbruch
F
F
Böcker
D
D
Hammel
D
D
Borggrefe
M
M
Scheld
H H
HH
Breithardt
G
G
D000293:Adolescent; D000328:Adult; D000368:Aged; D002423:Cause of Death; D002648:Child; D017147:Defibrillators, Implantable; D004566:Electrodes; D004868:Equipment Failure; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015996:Survival Rate; D017180:Tachycardia, Ventricular / Q000401:mortality / Q000628:therapy*
Therapie ventrikulärer Tachyarrhythmien mit implantierbaren Kardioverter/Defibrillatoren--Sterblichkeit und Komplikationen bei der Verwendung epikardialer Elektroden.